MUTANTS OF COMPLEMENT COMPONENT C3 CLEAVED BY THE C4-SPECIFIC C(1)-BAR-S PROTEASE

被引:8
作者
MATHIAS, P [1 ]
CARRILLO, CJ [1 ]
ZEPF, NE [1 ]
COOPER, NR [1 ]
OGATA, RT [1 ]
机构
[1] SCRIPPS RES INST, LA JOLLA, CA 92037 USA
关键词
D O I
10.1073/pnas.89.17.8125
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
To identify some of the structural features determining specific protease recognition of complement components C3 and C4, we used site-specific mutagenesis to construct mutants of murine C3 that are cleaved by the C4-specific C1sBAR protease. Insertion of three amino acid residues corresponding to residues at the C1sBAR cleavage site of human C4 into murine C3 at the analogous C3 convertase cleavage site was adequate to render the mutant protein susceptible to C1sBAR cleavage. In addition, insertion of C3-specific residues at the same site or introduction of the C4-specific residues as substitutions rather than as an insertion also rendered the site susceptible to cleavage, but with 10- to 50-fold lower efficiencies, and insertion of even a single amino acid residue affected recognition by C1sBAR. Finally, insertion of amino acid residues into mC3 partially inhibited cleavage by the alternative-pathway C3 convertase, with insertion of C3- or C4-specific residues giving about the same level of inhibition. A simple interpretation of these data is that C1sBAR cleavage is dependent primarily on steric accessibility and on recognition of specific amino acid residues at the cleavage site, whereas C3 convertase cleavage is dependent primarily on specific interactions distal to the cleavage site, with only relatively weak, non-C3-specific interactions at the cleavage site itself.
引用
收藏
页码:8125 / 8129
页数:5
相关论文
共 35 条
[1]  
ANDERSON MJ, 1992, J IMMUNOL, V148, P2795
[2]  
BELT KT, 1984, CELL, V36, P907
[3]  
CAMPBELL RD, 1988, ANNU REV IMMUNOL, V6, P161, DOI 10.1146/annurev.iy.06.040188.001113
[4]  
DEBRUIJN MHL, 1985, P NATL ACAD SCI USA, V82, P708
[5]  
EBANKS RO, 1992, J IMMUNOL, V148, P2803
[6]   STRUCTURAL AND FUNCTIONAL DIFFERENCES BETWEEN H-2 CONTROLLED SS AND SLP PROTEINS [J].
FERREIRA, A ;
NUSSENZWEIG, V ;
GIGLI, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (05) :1186-1197
[7]  
HAVILAND DL, 1991, J IMMUNOL, V146, P362
[8]   SULFATION OF TYROSINE RESIDUES INCREASES ACTIVITY OF THE 4TH COMPONENT OF COMPLEMENT [J].
HORTIN, GL ;
FARRIES, TC ;
GRAHAM, JP ;
ATKINSON, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (04) :1338-1342
[9]  
INOUYE S, 1987, SYNTHESIS APPLICATIO, P181